InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Champoux Jennifer. Director active across 1 company, notably Monte Rosa Therapeutics, Inc.. Aggregated, 12 filings have been logged. Split: 0 buy · 5 sells. Total volume traded: €162k. History available since 22 May 2026. The latest transaction was filed on 15 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Jennifer Champoux is Chief Operating Officer at Monte Rosa Therapeutics, Inc. (XNAS). She appears in 9 filings, and the sampled recent filings over the period from 2025-01-06 to 2026-06-25 show EUR 0 of purchases and EUR 72,958 of sales, with Levée d'options as the most common transaction nature.